The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

Cameron S. Brandt(Molecular Discovery (United Kingdom)), Myriam Baratin(Centre National de la Recherche Scientifique), Eugene C. Yi(Molecular Discovery (United Kingdom)), Jacob J. Kennedy(Molecular Discovery (United Kingdom)), Zeren Gao(Molecular Discovery (United Kingdom)), Brian A. Fox(Molecular Discovery (United Kingdom)), Betty Haldeman(Molecular Discovery (United Kingdom)), Craig Ostrander(Molecular Discovery (United Kingdom)), Tomonori Kaifu(Centre National de la Recherche Scientifique), Christian Chabannon(Centre de Recherche en Cancérologie de Marseille), Alessandro Moretta(University of Genoa), Robert West(Molecular Discovery (United Kingdom)), Wenfeng Xu(Molecular Discovery (United Kingdom)), Éric Vivier(Centre National de la Recherche Scientifique), Steven D. Levin(Molecular Discovery (United Kingdom))
The Journal of Experimental Medicine
June 15, 2009
Cited by 664Open Access
Full Text

Abstract

Cancer development is often associated with the lack of specific and efficient recognition of tumor cells by the immune system. Natural killer (NK) cells are lymphocytes of the innate immune system that participate in the elimination of tumors. We report the identification of a tumor cell surface molecule that binds NKp30, a human receptor which triggers antitumor NK cell cytotoxicity and cytokine secretion. This previously unannotated gene belongs to the B7 family and, hence, was designated B7-H6. B7-H6 triggers NKp30-mediated activation of human NK cells. B7-H6 was not detected in normal human tissues but was expressed on human tumor cells, emphasizing that the expression of stress-induced self-molecules associated with cell transformation serves as a mode of cell recognition in innate immunity.


Related Papers

No related papers found

Powered by citation graph analysis